This article was originally published on TipRanks.com American pharmaceutical company Eli Lilly and Company’s (NYSE: LLY) COVID-19 antiviral treatment, bebtelovimab, has received authorization for …
This article was originally published on TipRanks.com American healthcare and drug manufacturer Eli Lilly and Co.
This article was originally published on TipRanks.com Pharmaceutical corporation Eli Lilly and Company (NYSE: LLY) recently announced that it is looking to invest $1 billion to develop …
This article was originally published on TipRanks.com Eli Lilly and Company (NYSE: LLY) has signed a worldwide collaboration and exclusive licensing agreement with Abbisko Therapeutics Co.
This article was originally published on TipRanks.com Shares of the global healthcare company, Eli Lilly and Company (LLY) reached a new all-time high …
This article was originally published on TipRanks.com Loxo Oncology, the research and development group of Eli Lilly and Company (NYSE: LLY) has signed a strategic collaboration agreement with Foghorn …
This article was originally published on TipRanks.com Pharmaceutical corporation Eli Lilly and Company (LLY) recently announced that it has entered into a multi-year research collaboration and …
This article was originally published on TipRanks.com Eli Lilly and Company’s (LLY) antibody treatment has received expanded Emergency Use Authorization from the U.
American pharmaceutical company Eli Lilly and Company (LLY) has posted lower-than-expected earnings for the third quarter of 2021. However, revenues surpassed analysts’ expectations …
Eli Lilly and Co. And Incyte reported data from their phase 3 study of baricitinib in hospitalized COVID-19 patients.